Last reviewed · How we verify

NCT05476536

Effectiveness of Technology for Metabolic Diseases Combined Sarcopenia

Status unknown NA Last updated 8 February 2023
What this trial tests

NA trial testing self-management skills and healthy technology APP in Metabolic Disease in 200 participants. Status unknown.

Timeline
15 February 2023
Primary endpoint
31 July 2023
31 July 2023

Quick facts

Lead sponsorChang Gung University of Science and Technology
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment200
Start date15 February 2023
Primary completion31 July 2023
Estimated completion31 July 2023
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Chang Gung University of Science and Technology

Who can join

Adults 40 to 90, any sex, with Metabolic Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The lifestyle program intervention program focusing on healthy dietary habit and exercise effectively prevents metabolic syndrome, sarcopenia or frailty. Thus, the purpose of this study was to assess the efficacy of intervention program on metabolic syndrome subjects in Taiwan.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Metabolic Disease

Currently open trials in the same condition.

Other Chang Gung University of Science and Technology trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05476536.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing